We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Assay intended for use by professionals and trained operators on the SAMBA II instrument system in clinical and point-of-care settings.
The third quarterly OSCAR transparency release for 2022 to 2023.
These reports present the findings from the evaluation of the Group Work Trial. The intervention is known as JOBS II internationally.
This summary captures key findings from Phase II (2017–2020) of the Secure Livelihoods Research Consortium
This Note provides the consolidated text of the revised explanatory notes to the SOLAS Chapter II-1 subdivision and damage stability regulations as set out in MSC.429(98)/Rev.2.
How to register your medical devices with the Medicines and Healthcare products Regulatory Agency (MHRA) for the markets in Great Britain and Northern Ireland
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.